Emcure Pharmaceuticals Limited has informed the Exchange regarding Notice of Postal Ballot
EMCURE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Emcure Pharmaceuticals has issued a Postal Ballot notice seeking shareholder approval to appoint Mr. C S Muralidharan (DIN: 00014740) as an Independent Director of the company. The appointment is for a term of 3 consecutive years, effective April 1, 2026, and is being sought via a Special Resolution. Mr. Muralidharan is a 63-year-old Cost & Management Accountant with around 40 years of corporate experience, including senior roles at Indian Oil Corporation, Ranbaxy Group, Lupin, Matrix Laboratories, Watson Group, and most recently as Group CFO of Sun Pharmaceutical Industries. E-voting will be open from March 26, 2026 (9:00 a.m.) to April 24, 2026 (5:00 p.m.), with results expected by April 28, 2026.
This is a routine governance event and is unlikely to materially affect the stock price. Bringing on a high-profile former pharma CFO with deep industry, finance, and M&A experience could be viewed positively by investors as a board-strengthening move.